Cardinal Health, Inc. (NYSE:CAH) Shares Sold by US Bancorp DE

US Bancorp DE reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.2% during the 4th quarter, HoldingsChannel reports. The firm owned 43,822 shares of the company’s stock after selling 1,436 shares during the quarter. US Bancorp DE’s holdings in Cardinal Health were worth $5,183,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Fisher Asset Management LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $368,000. SVB Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $231,000. Flputnam Investment Management Co. boosted its holdings in shares of Cardinal Health by 1.8% during the 4th quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company’s stock worth $21,358,000 after purchasing an additional 3,148 shares during the last quarter. Private Trust Co. NA boosted its holdings in shares of Cardinal Health by 11.0% during the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after purchasing an additional 92 shares during the last quarter. Finally, Fielder Capital Group LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $204,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.9 %

NYSE:CAH opened at $127.50 on Thursday. The stock’s fifty day moving average is $125.28 and its two-hundred day moving average is $118.57. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The stock has a market capitalization of $30.80 billion, a price-to-earnings ratio of 23.79, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

CAH has been the topic of several recent research reports. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $132.00 to $145.00 in a report on Monday, January 6th. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday, January 7th. Argus set a $148.00 price objective on Cardinal Health in a report on Tuesday, February 4th. Finally, TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.